Accordingly, d16:1 S1, and CTGF levels were elevated in RCC as compared to adjacent healthy tissue, suggesting that elevated plasma levels of d16:1 S1P may play a procarcinogenic role in the development of RCC via the induction of CTGF [17]. This evidence concerns the gene CCN2 and renal cell carcinoma.